- Report
- October 2024
- 149 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- October 2024
- 137 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- September 2024
- 129 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- September 2024
- 163 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- September 2024
- 167 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- September 2024
- 179 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- September 2024
- 157 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 215 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 220 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 184 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 178 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 143 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 173 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 144 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 151 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 168 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- August 2024
- 145 Pages
Global
From €2220EUR$2,500USD£1,925GBP
- Report
- July 2025
- 150 Pages
Global
From €3507EUR$3,950USD£3,042GBP
- Report
- April 2025
- 185 Pages
Global
From €3995EUR$4,500USD£3,466GBP
- Report
- February 2025
- 187 Pages
Global
From €3995EUR$4,500USD£3,466GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more